Ebastine

Results: 27



#Item
11NIH Public Access Author Manuscript Pharmacogenet Genomics. Author manuscript; available in PMC 2012 May 01. NIH-PA Author Manuscript

NIH Public Access Author Manuscript Pharmacogenet Genomics. Author manuscript; available in PMC 2012 May 01. NIH-PA Author Manuscript

Add to Reading List

Source URL: www.coriell.org

Language: English - Date: 2014-02-06 16:14:40
12Review paper  Cardiovascular safety of antihistamines Anna Olasińska-Wiśniewska1, Jerzy Olasiński2, Stefan Grajek1 1 Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland Head of Department:

Review paper Cardiovascular safety of antihistamines Anna Olasińska-Wiśniewska1, Jerzy Olasiński2, Stefan Grajek1 1 Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland Head of Department:

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
13Microsoft Word - X AP[removed]doc.doc

Microsoft Word - X AP[removed]doc.doc

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-06-08 09:30:52
14Antihistamines in driving and piloting  ORIGINAL Antihistamines in Drivers, Aircrew and Occupations of Risk

Antihistamines in driving and piloting ORIGINAL Antihistamines in Drivers, Aircrew and Occupations of Risk

Add to Reading List

Source URL: www.jiaci.org

Language: English - Date: 2013-12-25 07:15:41
1523882159T Clarinex 8.5x11 PI

23882159T Clarinex 8.5x11 PI

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-09-14 08:01:31
16

PDF Document

Add to Reading List

Source URL: www.aaia.ca

Language: English - Date: 2010-06-22 02:56:55
17These highlights do not include all the information needed to use XYZAL safely and effectively. See full prescribing information for XYZAL. XYZAL (levocetirizine dihydrochloride) 5 mg tablets 2.5 mg/5 mL (0.5 mg/mL) oral

These highlights do not include all the information needed to use XYZAL safely and effectively. See full prescribing information for XYZAL. XYZAL (levocetirizine dihydrochloride) 5 mg tablets 2.5 mg/5 mL (0.5 mg/mL) oral

Add to Reading List

Source URL: www.fda.gov

Language: English
18One Year Post Exclusivity Adverse Event Review: Desloratadine Pediatric Advisory Committee Meeting September 15, 2004

One Year Post Exclusivity Adverse Event Review: Desloratadine Pediatric Advisory Committee Meeting September 15, 2004

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-11-10 16:33:43
19Ethers / Piperazines / Pfizer / Cetirizine / Johnson & Johnson / Ebastine / Chemistry / Organic chemistry / Organochlorides

Pediatric Safety Review: Xyzal ( levocetirizine)

Add to Reading List

Source URL: www.fda.gov

Language: English
20HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CLARINEX safely and effectively. See full prescribing information for CLARINEX. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CLARINEX safely and effectively. See full prescribing information for CLARINEX. ®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-25 08:31:50